Host: |
Rabbit |
Applications: |
WB/IHC |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-MAP4 (942-1152) is suitable for use in Western Blot and Immunohistochemistry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000IHC-P 1:50-1:200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
MAP4 |
Gene ID: |
4134 |
Uniprot ID: |
MAP4_HUMAN |
Immunogen Region: |
942-1152 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 942-1152 of human MAP4 (NP_002366.2). |
Immunogen Sequence: |
TENIKHQPGGGRAKVEKKTE AAATTRKPESNAVTKTAGPI ASAQKQPAGKVQIVSKKVSY SHIQSKCGSKDNIKHVPGGG NVQIQNKKVDISKVSSKCGS KANIKHKPGGGDVKIESQKL NFKEKAQAKVGSLDNVGHLP AGGAVKTEGGGSEAPLCPGP PAGEEPAISEAAPEAGAPTS ASGLNGHPTLSGGGDQREAQ TLDSQIQETSI |
Post Translational Modifications | Phosphorylated at serine residues in K-X-G-S motifs by MAP/microtubule affinity-regulating kinase (MARK1 or MARK2), causing detachment from microtubules, and their disassembly. Phosphorylation on Ser-787 negatively regulates MAP4 activity to promote microtubule assembly. Isoform 3 is phosphorylated on Ser-337 and Ser-338. |
Function | Non-neuronal microtubule-associated protein. Promotes microtubule assembly. |
Protein Name | Microtubule-Associated Protein 4Map-4 |
Cellular Localisation | CytoplasmCytoskeletonMicrotubule Organizing CenterRecruitment To Microtubule Is Inhibited By Microtubules Polyglutamylation |
Alternative Antibody Names | Anti-Microtubule-Associated Protein 4 antibodyAnti-Map-4 antibodyAnti-MAP4 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance